Tapering Opioids: Guidelines and Strategies

Tapering opioid therapy is an important process for patients who no longer need or who are at risk of harm from continued opioid use. The goal of tapering is to gradually reduce the opioid dose while minimizing withdrawal symptoms and the risk of complications. The tapering process should be individualized based on each patient’s needs, history, and medical condition.

General Principles for Tapering

  • Patient-Specific Approach: The tapering schedule should be tailored to the individual patient, considering their length of opioid use, current dose, and any underlying concerns (e.g., addiction risk, co-existing medical conditions).
  • Slower Taper for Long-Term Users: Patients who have been using opioids for a long period of time generally require a slower taper to minimize withdrawal symptoms.
  • Clear Communication: Provide patients and their families with clear written and verbal instructions about the tapering process. This ensures they understand the importance of reducing the dose slowly and how to manage any withdrawal symptoms that may arise.
  • Monitoring and Support: Regular follow-up is essential to monitor for withdrawal symptoms and adjust the tapering schedule as needed. Consider offering psychological support or counseling during the tapering process.

Tapering Schedule

For Patients Without Addiction Issues

In patients who do not have addiction issues and are physically dependent on opioids, a gradual reduction is generally recommended. A 20-50% reduction in the opioid dose each week is a typical starting point. The goal is to balance a reduction in opioid use with minimizing withdrawal symptoms.

Medications to Manage Withdrawal Symptoms
  • Clonidine: Often prescribed at 0.1 mg 2-3 times daily to manage symptoms of abstinence syndrome, including nausea, diarrhea, muscle pain, and myoclonus (muscle jerks).
  • Adjuvant Medications:
    • Antidepressants may be used to manage symptoms like irritability, anxiety, and sleep disturbances.
    • Antiepileptics may be beneficial for managing neuropathic pain or other nerve-related symptoms.

Tapering Guidelines for Specific Medications

The following are general tapering recommendations for common opioid medications. The decrease should generally be 20-50% per week, with the taper rate slowing down as the dose is reduced.

Methadone:
  1. Initial Decrease: Decrease by 20-50% daily until the dose reaches 30 mg/day.
  2. Subsequent Decrease: Then reduce by 5 mg/day every 3-5 days until the dose reaches 10 mg/day.
  3. Final Decrease: After reaching 10 mg/day, decrease by 2.5 mg/day every 3-5 days until the medication is fully tapered.
Morphine SR/CR (Slow-Release/Controlled-Release):
  1. Initial Decrease: Decrease by 20-50% daily until the dose reaches 45 mg/day.
  2. Subsequent Decrease: Then reduce by 15 mg/day every 2-5 days.
  3. Final Decrease: Once the dose is lower, decrease by 2.5 mg/day every 3-5 days until tapering is complete.
Oxycodone CR (Controlled-Release):
  1. Initial Decrease: Decrease by 20-50% daily until the dose reaches 30 mg/day.
  2. Subsequent Decrease: Then reduce by 10 mg/day every 2-5 days.
  3. Final Decrease: Decrease by 5 mg/day every 3-5 days until the opioid is completely tapered.

When to Adjust the Tapering Process

  • Withdrawal Symptoms: If withdrawal symptoms are severe, the tapering schedule may need to be adjusted. This may involve temporarily halting the reduction or reducing the rate of taper.
  • Patient Concerns: If a patient expresses anxiety or discomfort with the tapering process, discuss the symptoms and reassure them. Offering emotional support and explaining the process in detail can ease the transition.
  • Physical or Psychological Issues: If the patient begins experiencing significant physical or psychological distress that cannot be managed with adjunctive therapies, consider adjusting the tapering schedule or exploring alternative treatment options (e.g., addiction treatment services).

Tapering and Supportive Care

Throughout the tapering process, it’s crucial to provide ongoing support for the patient. This may include:

  • Regular follow-up visits or check-ins to monitor progress and make adjustments.
  • Offering referrals to pain management specialists, counseling, or substance abuse treatment if the patient has concerns about addiction.
  • Recommending non-opioid pain management strategies (e.g., physical therapy, acupuncture, cognitive-behavioral therapy).

Additional Resources

  • Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain
  • Pain Management Opioid Taper Decision Tool

Sources:

  • These recommendations are based on expert consensus and current guidelines for opioid tapering and chronic pain management.
  • Webster LR, Dove B. Avoiding Opioid Abuse While Managing Pain: A Guideline for Practitioners. 1st Edition. North Branch, MN: Sunrise Press; 2007.
SideMenu
Scroll to Top